Responsiveness of various symptoms of vascular disorders to calcium antagonist.
D001161:Arteriosclerosis / Q000188:drug therapy; D002118:Calcium / Q000037:antagonists & inhibitors*; D002561:Cerebrovascular Disorders / Q000188:drug therapy; D002936:Cinnarizine / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D004311:Double-Blind Method; D006801:Humans; D007383:Intermittent Claudication / Q000188:drug therapy; D007871:Leg Ulcer / Q000188:drug therapy; D010292:Paresthesia / Q000188:drug therapy; D010879:Piperazines / Q000627:therapeutic use; D014652:Vascular Diseases / Q000188:drug therapy*; D014665:Vasodilator Agents / Q000627:therapeutic use; D014689:Venous Insufficiency / Q000188:drug therapy
D010879:Piperazines; D014665:Vasodilator Agents; D002936:Cinnarizine; D002118:Calcium